SUDOSCAN IN DIABETES: IDENTIFICATION AND FOLLOW-UP OF THE AT RISK DIABETIC FOOT The role of quantitative sudomotor testing Impeto Medical will present SUDOSCAN and the role of quantitative sudomotor testing during the 17th annual conference of WoundHSI, Wound Healing: Science & Industry, on 20-21 June 2019 at New York. The diabetic foot is a very …
Conference of WoundHSI 2019 SUDOSCAN presentation Read More »
SUDOSCAN at JNLF 2019. Meet us on booth n°13 from april 16th to 19th 2019.
Meet us on the next 2019 medical congress.
The Hospital Italiano of Buenos Aires presented the Sudoscan with our distributor Iraola y Cia. on World Diabetes Day
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
Website dedicated
to health professionals
I am a health professional
